Scarica l'app Stockscreener
40.01
4.28%
-1.79
Precedente Chiudi:
$41.80
Aprire:
$42.15
Volume 24 ore:
1.08M
Relative Volume:
0.98
Capitalizzazione di mercato:
$4.60B
Reddito:
$47.30M
Utile/perdita netta:
$-377.94M
Rapporto P/E:
-11.68
EPS:
-3.4256
Flusso di cassa netto:
$-300.64M
1 W Prestazione:
-11.66%
1M Prestazione:
-12.98%
6M Prestazione:
+26.33%
1 anno Prestazione:
+15.80%
Intervallo 1D:
$39.79
$42.85
Intervallo di 1 settimana:
$39.79
$46.05
Portata 52W:
$22.71
$49.82
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Nome
Scholar Rock Holding Corp
Settore
Industria
Telefono
857-259-3860
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Compare SRRK vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
40.01 | 4.60B | 47.30M | -377.94M | -300.64M | -3.4256 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Iniziato | Citigroup | Buy |
| 2025-11-18 | Iniziato | Wolfe Research | Outperform |
| 2025-10-09 | Iniziato | BofA Securities | Buy |
| 2025-09-17 | Iniziato | Barclays | Overweight |
| 2025-09-15 | Iniziato | Leerink Partners | Outperform |
| 2025-08-21 | Ripresa | Jefferies | Buy |
| 2025-07-30 | Ripresa | Raymond James | Strong Buy |
| 2025-07-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-11-26 | Reiterato | H.C. Wainwright | Buy |
| 2024-10-07 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-28 | Iniziato | Raymond James | Strong Buy |
| 2023-10-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-04-03 | Ripresa | Piper Sandler | Overweight |
| 2022-09-19 | Ripresa | H.C. Wainwright | Buy |
| 2022-07-12 | Iniziato | Truist | Buy |
| 2022-03-23 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-22 | Downgrade | Jefferies | Buy → Hold |
| 2021-11-19 | Iniziato | Piper Sandler | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-01-11 | Iniziato | Credit Suisse | Outperform |
| 2021-01-06 | Iniziato | JP Morgan | Overweight |
| 2020-03-12 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Scholar Rock Holding Corp Borsa (SRRK) Ultime notizie
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Scholar Rock at Barclays Conference: Strategic Moves in Healthcare By Investing.com - Investing.com Nigeria
Volatility Watch: Is Scholar Rock Holding Corporation stock undervalued right nowNew Guidance & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Scholar Rock at Barclays Conference: Strategic Moves in Healthcare - Investing.com India
Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26% - AOL.com
Scholar Rock at Leerink Conference: Strategic Path Amid FDA Delays By Investing.com - Investing.com Nigeria
Scholar Rock at Leerink Conference: Strategic Path Amid FDA Delays - Investing.com UK
Scholar Rock Jumps 7% on $550M Funding: Here’s Where the Stock Could Go in 2026 - TIKR.com
Will Scholar Rock’s Rising Losses, Shelf Filing and Apitegromab Push Change Scholar Rock Holding's (SRRK) Narrative - simplywall.st
Q1 EPS Estimates for Scholar Rock Boosted by HC Wainwright - MarketBeat
Can Scholar Rock Holding Corporation maintain sales growthWeekly Profit Summary & Weekly Breakout Watchlists - baoquankhu1.vn
A Look At Scholar Rock Holding (SRRK) Valuation After Wider Losses And New Shelf Registration - simplywall.st
FY2030 EPS Estimates for Scholar Rock Raised by Analyst - MarketBeat
Scholar Rock (SRRK) Q4 2025 Earnings Transcript - AOL.com
Fisher Asset Management LLC Has $19.86 Million Stock Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
SRRK SEC FilingsScholar Rock Holding 10-K, 10-Q, 8-K Forms - Stock Titan
Scholar Rock at TD Cowen Conference: Strategic Vision and Challenges By Investing.com - Investing.com South Africa
Scholar Rock at TD Cowen Conference: Strategic Vision and Challenges - Investing.com Nigeria
Piper Sandler raises Scholar Rock stock price target on SMA launch - Investing.com India
SRRK: Citigroup Raises Price Target to $58, Maintains Buy Rating | SRRK Stock News - GuruFocus
Citigroup Issues Positive Forecast for Scholar Rock (NASDAQ:SRRK) Stock Price - MarketBeat
Scholar Rock Holding (SRRK) Sees Price Target Raised by Truist S - GuruFocus
Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, BMO Capital Markets Analyst Says - MarketBeat
Piper Sandler Raises Price Target for SRRK to $58.00, Maintains Overweight Rating | SRRK Stock News - GuruFocus
Scholar Rock (NASDAQ:SRRK) Sees Unusually-High Trading Volume Following Earnings Beat - MarketBeat
Barclays Raises Price Target for Scholar Rock Holding (SRRK) to $53 | SRRK Stock News - GuruFocus
Piper Sandler Forecasts Strong Price Appreciation for Scholar Rock (NASDAQ:SRRK) Stock - MarketBeat
Scholar Rock Holding Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q4 2025 Earnings Call Transcript - Insider Monkey
Truist Raises Price Target on Scholar Rock Holding to $55 From $44, Keeps Buy Rating - marketscreener.com
Aisling Capital Management LP Takes $2.87 Million Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Decoding Scholar Rock Holding Corp (SRRK): A Strategic SWOT Insi - GuruFocus
SRRK Technical Analysis & ETF Price Forecast - Intellectia AI
Raymond James Maintains Strong Buy on Scholar Rock (SRRK) Mar 2026 - Meyka
Scholar Rock (NASDAQ: SRRK) posts 2025 loss, expands debt capacity - Stock Titan
Barclays raises Scholar Rock stock price target to $53 on debt deal - Investing.com India
Scholar Rock (SRRK) Revises Financial Results for Q4 2025 - GuruFocus
CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Yahoo Finance
Truist raises Scholar Rock stock price target on manufacturing progress By Investing.com - Investing.com Australia
Truist raises Scholar Rock stock price target on manufacturing progress - Investing.com
Raymond James reiterates Scholar Rock stock Strong Buy on debt facility - Investing.com India
Scholar Rock Q4 Earnings Call Highlights - MarketBeat
Scholar Rock (NASDAQ:SRRK) Shares Gap UpTime to Buy? - MarketBeat
Scholar Rock Q4 2025 Earnings Call Transcript - MarketBeat
Scholar Rock Holding (SRRK) Receives Reiterated 'Buy' Rating fro - GuruFocus
Scholar Rock (NASDAQ:SRRK) Given Buy Rating at HC Wainwright - MarketBeat
Scholar Rock Holding Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Wedbush Adjusts Price Target on Scholar Rock to $56 From $50, Maintains Outperform Rating - marketscreener.com
Earnings call transcript: Scholar Rock Q4 2025 shows slight EPS beat, stock rises - Investing.com
Scholar Rock Holding Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Scholar Rock (SRRK) Poised for FDA Resubmission of Apitegromab - GuruFocus
Scholar Rock Holding Corp Azioni (SRRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):